We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,181 results
  1. Drug induced nephrotoxicity- A mechanistic approach

    The main goal of the treatment of patients is its effectiveness and safety. However, all currently prescribed drugs being used also have certain...

    Veerta Sharma, Thakur Gurjeet Singh in Molecular Biology Reports
    Article 28 June 2023
  2. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy

    Cancer stem cells (CSCs), a rare subset of cancer cells, are well known for their self-renewing capacity. CSCs play a critical role in therapeutic...

    Simin Zhang, Zhen Yang, Fazhi Qi in Molecular Biology Reports
    Article 14 December 2019
  3. Role of Bioinformatics in Drug Design and Discovery

    Bioinformatics can speed up the identification of therapeutic targets, screening drug candidates, and refinement of those candidates. It can also...
    Pinkal H. Patel, Adarsh Jha, G. S. Chakraborthy in CADD and Informatics in Drug Discovery
    Chapter 2023
  4. Application of CRISPR–Cas Technology in Drug Development

    The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)-Cas technology has transformed the science of genome editing,...
    Sidra Altaf, Faiza Saleem, ... Haseeb Anwar in Trends in Plant Biotechnology
    Chapter 2024
  5. Role of Fra-2 in cancer

    Fos-related antigen-2 (Fra-2) is the most recently discovered member of the Fos family and, by dimerizing with Jun proteins, forms the activator...

    Gian Luca Rampioni Vinciguerra, Marina Capece, ... Carlo M. Croce in Cell Death & Differentiation
    Article Open access 16 December 2023
  6. Nanoscale Smart Drug Delivery Systems and Techniques of Drug Loading to Nanoarchitectures

    Conventional drug delivery systems suffer from less therapeutic efficiency with adverse side effects and poor specificity in action. The progression...
    B. Varalakshmi, T. Karpagam, ... B. Balamuralikrishnan in Emerging Nanomaterials for Advanced Technologies
    Chapter 2022
  7. Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives

    Epithelial ovarian cancer (EOC) is a complex disease with diverse histological subtypes, which, based on the aggressiveness and course of disease...
    Megha Mehrotra, Pratham Phadte, ... Pritha Ray in Cell and Molecular Biology of Ovarian Cancer
    Chapter 2024
  8. Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus

    The advancement in pharmaceutical research has led to the discovery and development of new combinatorial life-saving drugs. Rapamycin is a macrolide...

    Sanjeev K. Ganesh, C. Subathra Devi in Molecular Biology Reports
    Article 25 January 2023
  9. Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment

    Drug resistance in leukaemia is a major problem that needs to be addressed. Precision medicine provides an avenue to reduce drug resistance through a...
    Vanelle Larissa Kenmogne, Ekene Emmanuel Nweke, ... Deepak B. Thimiri Govinda Raj in Cell Biology and Translational Medicine, Volume 19
    Chapter 2022
  10. Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine

    In recent years, the rapid emergence of 3D organoid technology has garnered significant attention from researchers. These miniature models accurately...

    Yujia Yang, Yajie Kong, ... Cuiqing Ma in Stem Cell Reviews and Reports
    Article 27 March 2024
  11. Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors

    Meningioma is the most common central nervous system (CNS) tumor. In recent decades, several efforts have been made to eradicate this disease....

    Swati Sharma, Rashmi Rana, ... Nirmal Kumar Ganguly in Molecular and Cellular Biochemistry
    Article 04 April 2023
  12. A novel approach to predicting the synergy of anti-cancer drug combinations using document-based feature extraction

    Background

    To reduce drug side effects and enhance their therapeutic effect compared with single drugs, drug combination research, combining two or...

    Yongsun Shim, Munhwan Lee, ... Hong-Gee Kim in BMC Bioinformatics
    Article Open access 05 May 2022
  13. Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1

    Antibody drug conjugates (ADCs) with twelve FDA approved drugs, known as a novel category of anti-neoplastic treatment created to merge the...

    Vahab Ziaei, Alireza Ghassempour, ... Mahdi Habibi-Anbouhi in Molecular and Cellular Biochemistry
    Article 02 May 2023
  14. The Causal Relationship between PCSK9 Inhibitors and Osteoporosis Based on Drug-Targeted Mendelian Combined Mediation Analysis

    PCSK9 inhibitors have been shown to lower serum low density lipoprotein cholesterol (LDL - C) levels and are considered integral in the treatment of...

    Naidan Zhang, Chaixia Ji, ... Chengliang Yuan in Calcified Tissue International
    Article Open access 24 May 2024
  15. Involvement and targeted intervention of benzo(a)pyrene-regulated apoptosis related proteome modification and muti-drug resistance in hepatocellular carcinoma

    During the development of hepatocellular carcinoma (HCC), the mutual adaptation and interaction of HCC cells and the microenvironment play an...

    Ye Yang, Ming **, ... Liming Tang in Cell Death & Disease
    Article Open access 12 April 2023
  16. A potent ion channel blocker, hydroquinidine, exhibits strong anti-cancer activity on colon, pancreatic, and hepatocellular cancer cells

    Background

    Despite recent advances in drug discovery, cancer is still one of the most lethal health problems worldwide. In most cases, standard...

    Mervenur Yavuz, Turan Demircan in Molecular Biology Reports
    Article 12 January 2023
  17. Aquaporins in colorectal cancer: exploring their role in tumorigenesis, metastasis, and drug response

    Aquaporins (AQPs) are small, integral proteins facilitating water transport across plasma cell membranes in response to osmotic gradients. This...

    Maryam Azimi Mohammadabadi, Ali Moazzeni, ... Elahe Safari in Human Cell
    Article 29 May 2024
  18. The role of epigenetic modifications in drug resistance and treatment of breast cancer

    Background

    Breast cancer is defined as a biological and molecular heterogeneous disorder that originates from breast cells. Genetic predisposition is...

    Mohsen Karami Fath, Ali Azargoonjahromi, ... Zahra Payandeh in Cellular & Molecular Biology Letters
    Article Open access 28 June 2022
  19. Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR

    Autophagy is a biological process that maintains cellular homeostasis and regulates the internal cellular environment. Hyperactivating autophagy to...

    Boah Lee, Seung Ju Park, ... Seyun Kim in Cell Death & Disease
    Article Open access 12 July 2022
  20. Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells

    Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer relapse. This resistance mostly originates from rare, but...

    Hamed Rezayatmand, Mahboobeh Razmkhah, Iman Razeghian-Jahromi in Stem Cell Research & Therapy
    Article Open access 03 May 2022
Did you find what you were looking for? Share feedback.